These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 28324867)

  • 1. Blood glucose levels and glycaemic burden in 76,341 patients attending primary care: Bittersweet findings from a 9-year cohort study.
    Carrington MJ; Cohen N; Wiley JF
    Diabetes Res Clin Pract; 2017 May; 127():89-96. PubMed ID: 28324867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW; Baggesen LM; Søgaard M; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabetologia; 2015 Oct; 58(10):2247-53. PubMed ID: 26277380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
    Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
    Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between number of contacts between previous dropouts with type 2 diabetes and health care professionals on glycaemic control: A cohort study in public primary health care.
    Kauppila T; Eriksson JG; Honkasalo M; Raina M; Laine MK
    Prim Care Diabetes; 2019 Oct; 13(5):468-473. PubMed ID: 30928432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of glycaemic deterioration in a real-world population with type 2 diabetes.
    Donnelly LA; Zhou K; Doney ASF; Jennison C; Franks PW; Pearson ER
    Diabetologia; 2018 Mar; 61(3):607-615. PubMed ID: 29260253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control.
    Goddijn PP; Bilo HJ; Feskens EJ; Groeniert KH; van der Zee KI; Meyboom-de Jong B
    Diabet Med; 1999 Jan; 16(1):23-30. PubMed ID: 10229289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS).
    Aschner P; Gagliardino JJ; Ilkova H; Lavalle F; Ramachandran A; Mbanya JC; Shestakova M; Chantelot JM; Chan JCN
    Diabetologia; 2020 Apr; 63(4):711-721. PubMed ID: 31901950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic status and time in glucose target range in people with type 2 diabetes: a baseline analysis of the GP-OSMOTIC study.
    Tan ML; Manski-Nankervis JA; Thuraisingam S; Jenkins A; O'Neal D; Furler J
    BMC Endocr Disord; 2018 Jul; 18(1):47. PubMed ID: 30031385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study.
    Calvert MJ; McManus RJ; Freemantle N
    Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes.
    Iqbal N; Morgan C; Maksoud H; Idris I
    Ann Clin Biochem; 2008 Sep; 45(Pt 5):504-7. PubMed ID: 18753424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences and correlates of poor glycaemic control in type 2 diabetes: a cross-sectional study in Brazil and Venezuela.
    G Duarte F; da Silva Moreira S; Almeida MDCC; de Souza Teles CA; Andrade CS; Reingold AL; Moreira ED
    BMJ Open; 2019 Mar; 9(3):e023401. PubMed ID: 30842107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
    Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
    Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate in-patient management of hyperglycaemia--confusion rather than consensus?
    Penfold S; Gouni R; Hamilton P; Richardson T; Kerr D
    QJM; 2008 Feb; 101(2):87-90. PubMed ID: 18180257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on short-term glycaemic control of initiating diabetes care versus leaving diabetes untreated among individuals with newly screening-detected diabetes in Japan.
    Heianza Y; Suzuki A; Fujihara K; Tanaka S; Kodama S; Hanyu O; Sone H
    J Epidemiol Community Health; 2014 Dec; 68(12):1189-95. PubMed ID: 25187645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Year longitudinal study of determinants of glycemic control for multi-ethnic Asian patients with type 2 diabetes mellitus managed in primary care.
    Tan NC; Barbier S; Lim WY; Chia KS
    Diabetes Res Clin Pract; 2015 Nov; 110(2):218-23. PubMed ID: 26385596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.